Transarterial Chemoembolization (TACE) of Liver Metastases Derived from Neuroendocrine Tumors is an Effective Treatment only in Patients with Low or Mediate Hepatic Tumor Burden

被引：0
|
作者：
Rinke, A.
Koenig, A.
Mueller, D.
Koenig, U.
Gress, T.
Burbelko, M. [1 ]
Kalinowski, M. [1 ]
机构：
[1] Univ Hosp Marburg, Marburg, Germany
来源：
NEUROENDOCRINOLOGY | 2010年 / 92卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] Treatment experience of hepatic metastases from neuroendocrine tumors using transarterial chemoembolization
    Trifanov, V. S.
    Kolesnikov, E. N.
    Snezhko, A., V
    Chernyak, M. N.
    Bazaev, A. L.
    Meshcheryakova, M. Y.
    YAKUT MEDICAL JOURNAL, 2020, (01): : 109 - 111
  • [2] Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors
    Francesco Fiore
    Michela Del Prete
    Renato Franco
    Vincenzo Marotta
    Valeria Ramundo
    Francesca Marciello
    Antonella Di Sarno
    Anna Chiara Carratù
    Chiara de Luca di Roseto
    Annamaria Colao
    Antongiulio Faggiano
    Endocrine, 2014, 47 : 177 - 182
  • [3] Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors
    Fiore, Francesco
    Del Prete, Michela
    Franco, Renato
    Marotta, Vincenzo
    Ramundo, Valeria
    Marciello, Francesca
    Di Sarno, Antonella
    Carratu, Anna Chiara
    di Roseto, Chiara de Luca
    Colao, Annamaria
    Faggiano, Antongiulio
    ENDOCRINE, 2014, 47 (01) : 177 - 182
  • [4] Experience in Treatment of Hepatic Metastases of Neuroendocrine Tumors Using Transarterial Chemoembolization
    Trifanov, V
    Kit, O.
    Kolesnikov, E.
    Chernyak, M.
    Snezhko, A.
    Ziyavdinov, F.
    Mezensev, S.
    Mesheryakova, M.
    Bazaev, A.
    NEUROENDOCRINOLOGY, 2019, 108 : 140 - 140
  • [5] Effects of Transarterial Chemoembolization of Liver Metastases from Neuroendocrine Tumors on Clinical Outcome
    Ognjanovic, S.
    Petakov, M.
    Macut, D.
    Isailovic, T.
    Elezovic, V
    Popovic, B.
    Bozic, I
    Bogavac, T.
    Colic, M.
    Damjanovic, S.
    NEUROENDOCRINOLOGY, 2012, 96 : 52 - 52
  • [6] Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Kitano, Mio
    Davidson, Gail W.
    Shirley, Lawrence A.
    Schmidt, Carl R.
    Guy, Gregory E.
    Khabiri, Hooman
    Dowell, Joshua D.
    Shah, Manisha H.
    Bloomston, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (12) : 4008 - 4015
  • [7] Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
    Mio Kitano
    Gail W. Davidson
    Lawrence A. Shirley
    Carl R. Schmidt
    Gregory E. Guy
    Hooman Khabiri
    Joshua D. Dowell
    Manisha H. Shah
    Mark Bloomston
    Annals of Surgical Oncology, 2016, 23 : 4008 - 4015
  • [8] Transarterial chemoembolization (TACE) in liver metastases of neuroendocrine tumors using streptozocin and tris-acryl microspheres (Embozar)
    Rougier, P.
    Pelage, J.
    Beauchet, A.
    Lagrange, C.
    Lepere, C.
    Bachet, J.
    El Hajjam, M.
    Veuillez, V.
    Nordlinger, B.
    Lacombe, P.
    Mitry, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 62 - 62
  • [9] Prognostic factors for patients undergoing trans-arterial chemoembolization (TACE) for the treatment of liver metastases from neuroendocrine tumors
    Dong, XD
    Yin, X
    Zeh, HJ
    Bartlett, DL
    Brown, CK
    Carr, BI
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 65 - 65
  • [10] Repeated transarterial chemoembolization (TACE) in the treatment of patients with liver metastases of breast cancer: Local tumor control and survival
    Vogl, T. J.
    Bauer, R.
    Eichler, K.
    Gruber, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345